Bach P, Ti L Hepatitis C and stimulant use disorder: challenges and opportunities Clin Infect Dis, 2020. PubMed

Long V, Arredondo J, Ti L, Grant C, DeBeck K, Milloy MJ, Lysyshyn M, Wood E, Kerr T, Hayashi K Factors associated with drug checking service utilization among people who use drugs in a Canadian setting Harm Reduct J, 2020. PubMed

Ryan A, Sereda A, Fairbairn N Measures to support a safer drug supply CMAJ, 2020. PubMed

Beaulieu T, Barbic S, Milloy MJ, Puri N, Hayashi K, Ti L PMH24 Factors associated with receiving integrated care among people with concurrent opioid use disorder and mental illness in a Canadian setting Value Health, 2020. Link

Lake S, St. Pierre M The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: a systematic review Clin Psychol Rev, 2020. PubMed

MacKinnon L, Socías ME, Bardwell G COVID-19 and overdose prevention: challenges and opportunities for clinical practice in housing settings J Subst Abuse Treat, 2020. PubMed

Bach P, Garrod E, Robinson K, Fairbairn N An acute care contingency management program for the treatment of stimulant use disorder: a case report J Addict Med, 2020. PubMed

Collins AB, McNeil R, Czechaczek S, Boyd J "That’s what I’m supposed to do at work": gendered labor, self-care, and overdose risk among women who use drugs in Vancouver, Canada Crit Public Health, 2020. Link

Mayer S, Fowler A, Brohman I, Fairbairn N, Boyd J, Kerr T, McNeil R Motivations to initiate injectable hydromorphone and diacetylmorphine treatment: a qualitative study of patient experiences in Vancouver, Canada Int J Drug Policy, 2020. PubMed

Bach P, Hayashi K, Milloy MJ, Nosova E, Kerr T, Wood E, Fairbairn N Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: a gender-based analysis Drug Alcohol Rev, 2020. PubMed

Filter Publications

  • Year

    -
  • Reset filter